Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
208 | nsp13:A208T; | CL-3d; |
237 | nsp13:A237-; | CL-3b;CL-3f; |
237 | nsp13:A237S; | CL-3d; |
237 | nsp13:A237T; | CL-1a_3b;CL-1a_3c;CL-3b; |
267 | nsp13:A267T; | CL-3b;CL-3e; |
292 | nsp13:A292-; | CL-3d; |
292 | nsp13:A292S; | CL-1a_3d;CL-3b;CL-3d;CL-3e;CL-5; |
292 | nsp13:A292V; | CL-3e; |
296 | nsp13:A296-; | CL-1a_3e;CL-3c;CL-3e; |
302 | nsp13:A302-; | CL-3e; |
302 | nsp13:A302D; | CL-1a; |
302 | nsp13:A302T; | CL-1b; |
302 | nsp13:A302V; | CL-3e; |
308 | nsp13:A308T; | CL-2;CL-3d; |
308 | nsp13:A308V; | CL-3f; |
316 | nsp13:A316T; | CL-3b;CL-3d;CL-3e; |
321 | nsp13:A321T; | CL-3c;CL-3e; |
336 | nsp13:A336-; | CL-1a_3c; |
338 | nsp13:A338-; | CL-3d;CL-5; |
338 | nsp13:A338T; | CL-3e; |
338 | nsp13:A338V; | CL-3b;CL-3d;CL-3e;CL-5; |
362 | nsp13:A362-; | CL-3b; |
362 | nsp13:A362V; | CL-3e; |
368 | nsp13:A368-; | CL-3b; |
368 | nsp13:A368T; | CL-3e; |
379 | nsp13:A379S; | CL-3c;CL-3e; |
379 | nsp13:A379V; | CL-1a_3d;CL-2;CL-3b;CL-3d; |
389 | nsp13:A389S; | CL-3d; |
389 | nsp13:A389V; | CL-1a_3d;CL-3b;CL-3d;CL-3e; |
393 | nsp13:A393-; | CL-3e; |
393 | nsp13:A393V; | CL-1a;CL-3d; |
403 | nsp13:A403-; | CL-3c;CL-3e;CL-3f; |
403 | nsp13:A403D; | CL-3d; |
403 | nsp13:A403T; | CL-3e; |
403 | nsp13:A403V; | CL-1a_3e;CL-3e; |
446 | nsp13:A446-; | CL-3e; |
446 | nsp13:A446D; | CL-3d; |
446 | nsp13:A446V; | CL-1a;CL-3a;CL-3c;CL-3d;CL-3e;CL-3f; |
454 | nsp13:A454V; | CL-1a;CL-3c;CL-3e;CL-3f; |
469 | nsp13:A469-; | CL-3e; |
469 | nsp13:A469D; | CL-3e;CL-3f; |
469 | nsp13:A469S; | CL-3d; |
469 | nsp13:A469T; | CL-2;CL-3e; |
469 | nsp13:A469V; | CL-3b;CL-3e; |
4 | nsp13:A4S; | CL-3b;CL-3e;CL-3f; |
505 | nsp13:A505-; | CL-1a_3b;CL-1b;CL-3c;CL-3d;CL-3e; |
509 | nsp13:A509G; | CL-1a; |
520 | nsp13:A520-; | CL-3b;CL-3d; |
520 | nsp13:A520S; | CL-3e; |
520 | nsp13:A520T; | CL-3f; |
Page 175 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com